Whitehawk Therapeutics (WHWK) Restructuring Costs (2019 - 2024)
Whitehawk Therapeutics' (WHWK) quarterly Restructuring Costs came in at $2.6 million in Q3 2024, up 6897.22% on a QoQ basis from -$38810.0 in Q3 2019.
Whitehawk Therapeutics (WHWK) Restructuring Costs (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Restructuring Costs data on file, last reported at $2.6 million in Q3 2024.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $2.6 million in Q3 2024; TTM through Dec 2025 was $2.6 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $2.6 million, changed N/A from the prior year.
- Restructuring Costs for Q3 2024 stood at $2.6 million, up from -$38810.0 in the prior quarter.
- Over the last five years, Restructuring Costs for WHWK reached as high as $2.6 million in Q3 2024 and fell as low as $2.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.64 Mn |
| Sep 30, 2019 | -38,810.00 |